Co-Authors
This is a "connection" page, showing publications co-authored by Giancarlo Ceccarelli and Guido Antonelli.
Connection Strength
0.370
-
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19). Virus Res. 2021 04 02; 295:198283.
Score: 0.058
-
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. Medicine (Baltimore). 2020 Sep 04; 99(36):e21803.
Score: 0.056
-
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease. J Glob Antimicrob Resist. 2020 12; 23:67-69.
Score: 0.056
-
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
Score: 0.056
-
Increased IL-17 and/or IFN-? producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS. 2019 03 15; 33(4):627-636.
Score: 0.051
-
Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation. J Immunol Res. 2018; 2018:1738676.
Score: 0.049
-
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun Inflamm Dis. 2017 09; 5(3):244-260.
Score: 0.045